Overview

  • Product nameAnti-RDM1 antibody
    See all RDM1 primary antibodies
  • Description
    Rabbit polyclonal to RDM1
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide derived from an internal sequence of Human RDM1.

  • Positive control
    • Paraffin embedded Human colon carcinoma tissue.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage bufferpH: 7.40
    Preservative: 0.02% Sodium azide
    Constituents: 49.1% PBS, 0.88% Sodium chloride, 50% Glycerol
    Note: PBS is without Mg2+ and Ca2+.
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab111139 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

  • FunctionMay confer resistance to the antitumor agent cisplatin. Binds to DNA and RNA.
  • Tissue specificityExpressed in testis.
  • Sequence similaritiesContains 1 RRM (RNA recognition motif) domain.
  • DomainC-terminal half (amino acids 134-284) contains cytoplasmic retention domains as well as determinants involved in its stress-induced nucleolar accumulation.
  • Cellular localizationCytoplasm. Nucleus > PML body. Nucleus > Cajal body. Isoform 1 is predominantly cytoplasmic. Isoform 1 colocalized with nuclear promyelocytic leukemia (PML) and Cajal bodies (CB); this association with nuclear bodies is enhanced in response to proteotoxic stress; Nucleus. Cytoplasm. Nucleus > nucleolus. Isoform 3 and isoform 10 are predominantly nuclear and nucleolar. After treatment with proteasomal inhibitors and mild heat-shock stress, isoform 1, isoform 3, isoform 5, isoform 7, isoform 8 and isoform 10 are relocalized to the nucleolus as dot-like or irregular subnuclear structures. Isoform 1 colocalized with nuclear promyelocytic leukemia (PML) and Cajal bodies (CB) and this association with nuclear bodies is enhanced in response to proteotoxic stress. Isoform 3, but not isoform 1 and isoform 5, is relocalized in nucleolar caps during transcriptional arrest.
  • Information by UniProt
  • Database links
  • FormThere are 11 isoforms produced by alternative promoter usage and alternative splicing.Isoform 1 = RDM1alpha; Long N-terminal form. Isoform 2 = DeltaN-RDM1alpha; Short N-terminal form. Isoform 3 = RDM1beta. Isoform 4 = DeltaN-RDM1beta. Isoform 5 = RDM1gamma. Isoform 6 = DeltaN-RDM1gamma. Isoform 7 = RDM1delta. Isoform 8 = RDM1epsilon. Isoform 9 = DeltaN-RDM1epsilon. Isoform 10 = RDM1zeta. Isoform 11 = DeltaN-RDM1zeta.
  • Alternative names
    • MGC33977 antibody
    • RAD52 homolog B antibody
    • RAD52 motif 1 antibody
    • RAD52 motif containing 1 antibody
    • RAD52 motif-containing protein 1 antibody
    • RAD52B antibody
    • RDM1 antibody
    • RDM1_HUMAN antibody
    see all

Anti-RDM1 antibody images

  • ab111139, at a 1/50 dilution, staining RDM1 in paraffin embedded Human colon carcinoma tissue by Immunohistochemistry. Image on the right was from tissue treated with the synthetic peptide.

References for Anti-RDM1 antibody (ab111139)

ab111139 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab111139.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"